DNM3OS Enhances the Apoptosis and Senescence of Spermatogonia Associated with Nonobstructive Azoospermia by Providing

Rui Hua1, Qingjun Chu1, Feiyan Guo1

  • 1Center for Reproductive Medicine, Department of Obstetrics and Gynecology, Nanfang Hospital, Southern Medical University, Guangzhou, China.

Abstract

Insights

Long noncoding RNA DNM3OS regulates spermatogonia apoptosis and senescence via miR-214-5p and E2F2. This finding suggests DNM3OS as a potential gene therapy target for male infertility caused by nonobstructive azoospermia.

Area of Science:

  • Reproductive Biology
  • Molecular Genetics
  • Cell Biology

Background:

  • Nonobstructive azoospermia (NOA) involves testicular spermatogenic dysfunction.
  • The role of long noncoding RNAs (lncRNAs) in NOA pathogenesis is not well understood.

Purpose of the Study:

  • To identify differentially expressed lncRNAs and mRNAs in NOA testicular tissue.
  • To investigate the functional role of identified lncRNAs in spermatogonial cells.

Main Methods:

  • Microarray analysis of testicular biopsy samples from NOA patients and controls.
  • Quantitative real-time PCR for verification.
  • In vitro studies using Adriamycin-treated GC-1 spermatogonia cells.
  • Bioinformatic prediction of miRNA-mRNA interactions.
  • Functional assays including CCK-8, EdU, apoptosis, and senescence staining.

Main Results:

  • Over 2,600 lncRNAs and mRNAs were differentially expressed in NOA patients.
  • DNM3OS was identified as a regulator of miR-214-5p, which targets E2F2.
  • Knockdown of DNM3OS or miR-214-5p ameliorated Adriamycin-induced damage in GC-1 cells, reducing apoptosis and senescence.

Conclusions:

  • DNM3OS regulates spermatogonial apoptosis and senescence by modulating the miR-214-5p/E2F2 axis.
  • DNM3OS represents a potential novel therapeutic target for male infertility associated with NOA.